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Zymbal glands were excised bilaterally from the ear ducts offemale Sprague-Dawley rats (three/group),
minced into approximately fourfragments pergland, and transferred into amicrotiterplate containing 1.5
mLperwell ofWaymouth's tissue culture medium supplemented with fetal calfserum, hydrocortisone, in-
sulin, and gentamicin. Afteraddition ofatestcompoundorsolventvehicle, plates were incubatedfor6, 24,
48, or 96 hr at 37°C in a humidified atmosphere of 5% CO2 in air. Tissue in culture for 6 hr was histologi-
cally indistinguishable from the freshly excised tissue, while that in culture for 24, 48, and 96 hr showed a
progressive deterioration often with necrosis and/or squamous metaplasia. More pronounced deterioration
wasnotedinsamplestreated with 750or1500pg/mLofbenzene. UsinganucleasePi-enhanced32P-postlabeling
assay, aromatic DNAadducts were detected in cultured Zymbal glands exposed for 48 hrto benzene and its
derivatives, as well as to 7,12-dimethylbenzanthracene (DMBA) and 2-acetylaminofluorene (AAF). Benzene
produced very low levels ofadducts (0.5 adducts per 109 nucleotides), whereas its congeners produced rela-
tively high levels ofadducts (50-2000 lesions per109nucleotides), whichdecreased in theorderbenzoquinone
> hydroquinone > phenol > benzenetriol > catechol. Each adduct profile overall was characteristic for
the compound studied, suggesting the formation ofcompound-specific electrophiles. AAF and DMBA ad-
ducts were identical to those formed in vivo in animals. Our results show that the Zymbal glands are capa-
ble ofmetabolizing different carcinogens to DNA-reactive intermediates, a process that may be causally as-
sociated with tumor formation in vivo in this organ.
Introduction
Rat Zymbalglands, located at thebase ofthe external
auditory canal, have adistinctivepink-yellow color,weigh
about 7 to 8 mg, andhave adiameterof3 to 5 mm. These
glands, also present in otherrodents andinsectivores, but
not in humans, have a typical sebaceous morphology,
which is characterized by rounded sacs of plump, fat-
containing cells(1). These cells subsequently break down,
releasingfat droplets intothe external earcanal(1). Mal-
toni et al. (2) and the National Toxicology Program (3)
havereported adose-dependentfonnationofsolldtumors
in Zymbal glands of rats following administration of
repeated high dosesofbenzene. Themechanism bywhich
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benzene induces this canceris unknown, but it has been
suggested from in vitro and in vivo metabolism studies
that benzene is enzymatically activated to reactive inter-
mediatesthat canbind to DNA(4), therebyformingcova-
lent adducts, which, in turn, may causally be associated
with mutation and the initiation ofcarcinogenesis (5).
Theliver isgenerally consideredtobe the primary or-
gan for benzene metabolism, but the incidence of liver
tumors(hepatomas) hasbeenreported tobe three times
lowerthan that ofZymbalgland carcinomas inrats after
daily administration of500mg/kgbenzenefor 104weeks
(2). This difference in the susceptibility to carcinogene-
sis may, in part, derive from the unique metabolic capa-
bilities of Zymbal gland tissue.
In ordertofacilitate the study ofZymbalglandmetab-
olism, wehave devised aculture systemtomaintainfrag-
ments ofZymbal glands for several hours after excision
from rats. The capability of the cultured glands to
metabolize benzene and its derivatives [catechol,REDDY ETAL.
1,2,4-benzenetriol (BT), phenol, hydroquinone (HQ), and
benzoquinone (BQ)], as well as 7,12-dimethylbenzan-
thracene (DMBA) and 2-acetylaminofluorene (AAF), was
then assessed by measuring covalent binding of these
compounds to DNA using a highly sensitive 32P-post-
labeling assay (6,7). DNA adducts were readily detecta-
ble with all compounds tested, except benzene, which
produced relatively low levels of adducts. DMBA- and
AAF-DNA adduct profileswere similarto thoseformed
invivo inthe epidermis and Zymbalgland, respectively,
of treated animals.
Materials and Methods
Benzene was purchased from American Burdick and
Jackson, a subsidiary ofAmerican Hospital Supply Cor-
poration (Muskegon, MI). Catechol, BT, HQ, and BQ
were obtained fromAldrich Chemical Company. Phenol
(Mallinckrodt, Cat. No. 0025-2.5) was distilled prior to
use. DMBA, AAF, and calf thymus DNA were from
SigmaChemical Company. Waymouth's culture medium
and calf serum were from Gibco Laboratories. Carrier-
free y-32P-ATP (about 4000 Ci/mmole) was synthesized
from 32Pi(8) orpurchasedfrom ICN Radiochemicals (Cat.
No. 35020). Polyethyleneimine (PEI)cellulose plateswere
prepared (9) in the laboratory. The sources of all other
materials neededfor32P-postlabelinganalysis ofadducts
have been documented previously (6-8).
For the organ culture experiments, Zymbal glands
wereaseptically excisedfromboth theearductsoffemale
Sprague-Dawley rats(4 months ofage, weighingapprox-
imately 280 g), minced into four to six fragments per
gland, and placed into Waymouth's MB752/1 tissue cul-
ture medium supplemented with 10% fetal calf serum
(heat inactivated at 570C for 30 min), 350 Ag/mL gluta-
mine, 5;Ag/mL hydrocortisone, 5,ug/mL insulin, and0.1%
gentamicin (10). The gland fragments from three rats
were transferred into a24-well microtiter plate (1.5 mL
ofthe above mediumperwell), to whichwas added atest
chemical or solvent vehicle (1%, v/v). DMBA and AAF
were dissolved in DMSO, BTinethanol, andothersinwa-
ter. Final concentrations in the incubation media were:
DMBA, 5 Ag/mL; AAF, 40,ug/mL; benzene, 7500 Ag/mL
(solubility in wateris 1800 Ag/mL); others 750 and/or 1500
Ag/mL. The plates were incubated for 6, 24, 48, or 96 hr
at370C in a humidified atmosphere at5% CO2inair. For
the histopathological examination, freshly excised Zym-
balglands, aswell asthetreatedtissues, from eachofthe
time points were fixed in neutral formalin, embedded in
paraffin, cut at 6 iAm thick, and stained with hematoxy-
linandeosin. Fortheadduct study, tissueswere collected
at 12 hr (DMBA) or 48 hr (others) after treatment. In
vivo-modified AAF-DNAwasprepared from the Zymbal
glandsofrats at24 hr afterdaily oralgavage dosesof40
mg/kg AAF in ethanol/DMSO/olive oil (1:2:14, v/v, 3
ml/kg)for 5 days; control animals received solvent vehi-
cle alone.
DNA was isolated from the Zymbal glands by treat-
ment with ribonucleases (A, T1) and proteinase K, fol-
lowed by a solvent extraction as described previously
(11), except that the volumes of reagents were scaled
down by 3-fold. An average yield of DNA from pooled
Zymbalglands in several extractions correspondedto 17
(±6) ,ug DNA per rat. The presence ofadducts in DNA
was analyzed usinga nucleasePi-enhanced postlabeling
assay (7,8). Briefly, DNA (10-15 dig) was enzymatically
digested to 3'-deoxyribomonucleotides (12), which were
then treated with nuclease Pi, which dephosphorylates
nonnalnucleotidesbut notaromaticadducted nucleotides
(8). Thelatterwere 32P-labeledusingy-32P-ATPandpoly-
nucleotide kinase andresolvedby PEI-cellulose TLC ac-
cording to the following two methods.
Inmethod A, which utilizes the techniques previously
described (13-15), the adducted 32P-nucleotides ofAAF,
benzene, and its derivatives were purified on a PEI-
cellulose thin-layerplate (Fig. 1)in direction Dl in2.3 M
sodium phosphate, pH 5.77 (15), in situ magnet trans-
ferred to a second20 x 12.5-cm size PEI-cellulose sheet
(15), andresolvedby athree-directional development(15)
ofthe sheet in the following solvents: D3, 2.5 M lithium
formate, 4.7 M urea, pH 3.5, to 20 cm; D4, 0.4 M sodium
phosphate, 0.25 MTris-HCl, 4.25M urea, pH 8.0, to 12.5
cm; D5, 1.7 M sodium phosphate, pH 6.0, to 12.5 cm.
DMBAadductswere chromatographedthe samewayas
above exceptthe composition ofD3 and D4 solventswere
D3, 3.2Mlithiumformate, 6.0Murea, pH 3.5; D4, 6.4 M
sodium phosphate, 0.4 M Tris-HCl, 6.8 M urea, pH 8.0.
In method B, which was specially designed to permit
therecovery ofadditional adducts morepolar thanthose


















3 2. D4,D5 -_-
2.5
FIGURE 1. Scheme ofPEI-cellulose TLC for purification and separation
ofadducted 32P-nucleotides (method A). This scheme is essentially
the same as the onepreviously described by Lu et al. (15) with afew
minor modifications. 32P-Labeled DNA digests were applied to the
origins (a to g) ofa PEI-cellulose sheet that had been attached to a
Whatman paper No. 1 wickby stapling(A). The sheet was then de-
veloped in direction Dl to removeleftovery-32P-ATP and 32P-labeled
contaminants. Eachorigin area(shaded area)containingpurified aro-
matic adducts was cut out and attached to a second PEI-cellulose
sheet(B) with the aid ofbutton-type magnets forcontact-transfer of
adducts(15). The sheetwasthendeveloped alongD3,D4,andD5with
solventsgiveninthe texttotransferandresolve adducts. Measure-
ments are in centimeters.
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the origin(OR)ofaPEI-cellulose sheet(20 x 20 cm)(Fig.
2). It was then developed overnight (16-17 hr) in direc-
tion Dl in 1.7M sodium phosphate, pH 6.0, onto aWhat-
man No. 1 paperwickstapledto thetop ofthe sheet. The
wet sheet was cut below the paper wick, which was dis-
carded and soaked twice in 1 L of deionized water for 5
mineach. Afterdrying, itwas developedin D3, the same
direction as thepreceding development, with waterto 1
cm from the bottom edge, then with 1.9 M lithium for-
mate, 3.8 M urea, pH 3.5, to the top of the sheet. The
sheetwas soakedinwaterasbefore, dried, and developed
in D4, perpendicular to the preceding development, in
waterto 1 cm,followedby0.36M sodiumphosphate, 0.23
M Tris-HCl, pH 8.0, to the top, and dried. 32P-adducts
were detectedby screen-enhanced autoradiography(6,7).
Adduct radioactivity was determined by excising the
spots from the chromatograms and Cerenkov counting
(6,7). An estimation of adduct levels, expressed as rela-
tive adduct labeling(RAL), wasmade fromthevalues of
adduct count rates, adjusted for background radioac-
tivity, and the specific activity ofy-32P-ATP determined
by measuring the incorporation of 32p into a known
amount of dAp (7,8).
Results
Histopathological Examination of Tissues
Microscopic examination of the Zymbal glands main-







FIGURE 2. Scheme ofPEI-cellulose TLC forpurification and separation
ofpresumably lesshydrophobic adducts derivedfromphenolandHQ
(method B). 2P-Labeled digests were applied atthe origins(OR) of
aPEI-cellulosethin-layerplate, whichwas developedalong Dl to re-
move y-32P-ATP andpartiallyresolve adducts. Furtherresolution of
adductswas obtainedbydevelopment alongD3, D4, and D5withsol-
vents of composition given in the text. Measurements are in cen-
timeters.
any test substance revealed that the glands at 6 hr (not
shown) were histologically indistinguishable from those
at 0 hr, i.e., the freshly removed tissue (Fig. 3A), while
the ones at 24 (not shown), 48 (Fig. 3B), and 96 hr (Fig.
3C) exhibited a progressive deterioration often with
necrosis and/or squamous metaplasia.
Analysis of DMBA and AAF Adducts
Using the nuclease Pi-version of the 32P-postlabeling
assay (7,8), we detected DNA adducts in the Zymbal
glandstreatedin culturewith DMBA(5,ug/mL)andAAF
(401g/gL), bothbeing used in the present study as posi-
tive controls (Fig. 4). DMBAproduced two major (spots
1 and 8) and five minor adducts (Fig. 4B) that were not
detected in control DNA (Fig. 4A). The adduct pattern,
exceptforanadditionalproduct8, was qualitatively simi-
lar to that seen previously (7,8,16,17) in the epidermal
DNAofmice thathad been treatedbytopical application
with DMBA. Cerenkov counting revealed that adducts
1 and 8 together comprised 70% oftotal DNA modifica-
tions, which corresponded to 25 adducts in 109 DNA
nucleotides. Schmeiser et al. (18) have recently character-
ized adduct 1 asthemajorsyndihydrodiol epoxide deox-
yguanosine (dG)product, and adducts 3 and4 as the ma-
jor anti dihydrodiol epoxide derivatives of deoxya-
denosine (dA) and dG, respectively.
AAF produced four adduct spots (Fig. 4D) that were
chromatographically identical to those obtained in vivo
in Zymbal gland DNA of rats dosed orally with AAF
(Fig. 4E). Because some aromatic amine adducts are not
recovered completely by the nuclease Pi-enhanced 32P-
procedure (7,8), AAF adductswere also evaluatedby an
alternateprocedure involvingbutanolextractionofDNA
digestspriorto 32P-labeling(19). Moreradioactivity was
incorporated into spot 1 afterbutanol extraction(Fig. 4G,
4H)whencomparedwiththatafterexposure tonuclease
P1 (Fig. 4D, 4E), suggestingthe loss ofthis adductby en-
zymic3'-dephosphorylation. The recoveryofadduct 1 af-
ter nuclease Piwas 4% ofthat after butanol extraction;
adduct 2 was recovered similarly with and without the
enzyme (data not shown). Adduct 1, which has been
characterized previously as dpGp-C8-(N2-AF) (13), com-
posed89% oftotalmodifications, corresponding to 31 ad-
ducts per 109 DNA nucleotides. Modification of the in
vivo sample was about 540 lesions per 109 nucleotides,
with adduct 1 representing97% ofthe total. Adduct2has
previously been identified as dpGp-N2-(C3-AAF) (13).
Analysis ofAdducts from Benzene and Its
Derivatives
When DNA samples isolated from the Zymbal glands
that had been treated in culture with various derivatives
ofbenzene (1500mg/mL), aswell asbenzeneitself(r- 1800
pg/mL), were analyzed bythe nuclease Pi-amplified 32p-
postlabeling assay, the autoradiograms shown in Figure




FIGURE 3. Light photomicrographs ofrat Zymbal gland. (A) Freshly excised and fixed tissue. Focal fresh hemorrhage (arrow) in the supporting con-
nective tissue and the normal architecture ofthe gland are seen. (B) Zymbal glands maintained in the culture medium without a test substance
for 48 hr. Dissolution ofglandular epithelium forming cystic spaces, which are partially filled with cell debris, is seen. (C) Zymbal glands main-
tained in the culture medium without atest substance for96 hr. Large cystic spaces with cell debris and squamous metaplasia(arrow) oftheglan-
dular epithelium are present.
Continued on next page
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following exposure to different derivatives of benzene,
withunique adductprofilesforeachcompound. Catechol
produced onemainadduct(spot a) and several minor ones
(spotsb tom), some ofthe lattermigratedin areaswhere
the DNAderivatives ofBTmigrate. Phenolproduced one
major(spot 1) and seven minor adducts; HQ induced an
adduct pattern of3 major spots (spots 5 to 7) and many
minor adducts. With BQ-DNA, one major (spot 6) and a
few minor alterations were detected. The major adduct
was found to be a guanine derivative, as a chro-
matographically identicalproduct wasformed when dGp
was reacted in vitro with BQ and 32 P-labeled (data not
shown). With benzene-DNA, no adducts were detected
when the chromatogram was exposed to X-ray film for
the same time period as thatemployed forthe detection
of metabolite-DNA adducts; however, upon five times
longer film exposure, two faint adduct spots in the area
where themajorproducts ofBQandphenolmigrate were
seen when compared withthe control map leftin contact
with the film for the same period. Adducts exhibiting
similarmobilities on the 32p maps were tentatively iden-
tified by overlapping the autoradiograms. Unequivocal
evidence for the identity of adducts of interest would,
however, require chromatography of a mixture of 32p-
labeled DNAdigestsin additional solventsandusingdif-
ferentTLC systems(20). Asshown inFigure 6, when 32p-
labeled digests were chromatographed according to
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FIGURE 4. Autoradiograms of TLC maps of 32P-labeled DMBA and
AAF adducts. DNA specimens isolated from the Zymbalglands ex-
posedinculture (a-d,,g) orin vivo(e,h)to solventvehicle(a, DMSO;
candf, ethanolVDMSO/olive oil) and the indicated carcinogens were
digested to nornal and adducted nucleotides. The latter were en-
riched, 32P-labeled, contact-transferred, and resolved by TLC (15).
Adducts of DMBA (a, b) and AAF (c-e) were enriched by nuclease
Pi treatment andresolvedusing solventsgiven in the text. AAF ad-
ducts were also enriched bybutanol extraction(f-h)(19) and resolved
according to thepublished conditions (14) with modifications entail-
ing use of2.3 M sodium phosphate, pH 5.77, as a Dl solvent and a
magnet-transfer step after Dl development (15). Autoradiography
wasperformed at -800C for 2 hr(a, b), 5 hr(c, e), 15 hr(d), and 3 hr
(f-h). Faintadduct spots requiringlongerfilm exposure times(15-20




FIGURE 5. Autoradiograms ofTLC maps of32P-labeled DNA adducts derived from benzene and its derivatives. DNA samples isolated from Zym-
bal glands exposed in culture for 48 hr to the solvent vehicle (control) and the indicated compounds were digested and 32P-labeled. Labeled
adducts in DNA digests were purified, contact-transferred, and resolved by two-dimensional TLC according to method A outlined in Fig. 1.
D3 development was in the vertical direction, and D4 and D5 developments were in the horizontal direction. Autoradiographic conditions were:
control (top row), catechol and BT, -800C for8hr; phenol and HQ, -800C for2 hr; BQ, 230C for2 hr; control (bottom row) and benzene, -800C
for 36 hr. Note that the sensitivity of film detection is increased 3- to 4-fold at -800C relative to 230C. Chromatographically corresponding
adducts on maps of catechol and BT, as well as those of phenol, HQ, BQ, and benzene, were identified with the same letters or numbers.
method B, which permits recovery of derivatives more
polar than those detected above (Fig. 5), one additional
adduct(no. 23)withphenol-DNAand two(nos. 23and24)
with HQ-DNA were detected.
DNAmodifications with different benzene derivatives
ranged from 45 to 1980 adducts per 109 nucleotides and
decreased in the order BQ > HQ > phenol > BT >
catechol (Table 1). Phenol and HQ induced dose-
dependent adducts at two concentrations tested. More
BQadduct (no. 6)wasformedwhentheHQconcentration
was increased from 750 to 1500Hg/mL. The adductlevels
determined represent a minimum estimate, as the effi-
ciency oflabeling of various adducts and the extent of
their resistance to 3'-dephosphorylation by nuclease P1
are unknown, except for adduct 6 whichwas found com-
pletely resistant to nucleasePi-mediated3'-dephosphory-
lation (21).
Discussion
Inthisreport, we showforthe firsttime thatrat Zym-
balglands canbemaintained in culturefor aperiodlong
enough to studyearly effects ofgenotoxicants, e.g., DNA
adduct formation. Employing the nuclease Pi-enhanced
32P-postlabelingassay, DNAadductshavebeen detected
in Zymbal glands cultured in the presence of DMBA,
AAF, benzene, and its derivatives.
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FIGURE 6. Autoradiograms ofTLC maps of 32P-labeled DNA adducts
derived from phenol, HQ, and BQ. DNA specimensprepared as given
inthelegend ofFig. 5 were digested and 32P-labeled. Labeledadducts
in DNA digests were purified and resolved according to method B
outlined in Fig. 2. Dl and D3 developments wereinthe vertical direc-
tionandD4developmentinthehorizontal direction. Autoradiographic
conditions were similar to those given in the legend of Fig. 5.
Detection of DNA adducts with the indirect carcino-
gens, DMBA and AAF, indicates that Zymbal glands in
culture are capable ofmetabolically activating these car-
cinogens to electrophilic intermediates that can bind to
DNA. The activation pathways in the cultured Zymbal
glands appeartobe similar to those occurring invivo, in
asmuch as the adduct profiles(Fig. 4) were qualitatively
the same as those seen in vivo in DMBA-treated mouse
epidermal DNA (8,16-18) and in AAF-treated rat Zym-
bal glands in the present studies. DMBA, however, in-
duced an additional product (no. 8) in cultured Zymbal
gland, which has notbeen detected invivoin mouse skin
(8,16,17), suggestingtheformation ofsometissue-specific
reactive intermediates. DMBA and AAF metabo lsm is
mediatedby amixed-function oxidase system (22,23). Ad-
duct detection inZymbalglands is consistent with the ob-
servation by Pohl and Fouts (24), who have shown the
presence ofcytochrome P-450-dependent aryl hydrocar-
bon hydroxylase activity in rat Zymbal gland homoge-
nates.
The comparison of adduct patterns among different
benzene metabolites studied (Fig. 5) enables the predic-
tion ofpossible electrophiles formedfrom the individual
compounds. Metabolism studieswith liverand bone mar-
row (4,25,26) have shown that phenol can be oxidized to
catechol, HQ, andbiphenol by cytochrome P-450-depen-
dent monooxygenase, peroxidase, or active oxygen
released duringthe oxidative burst. Ourfindingsthatthe
major derivatives ofphenol(Fig. 5, adducts 1 and6)were
different from those of catechol and overlapped with a
fraction of HQ adducts suggest, but do not prove, that,
in cultured Zymbal glands, conversion of phenol to
catechol is negligible, while its conversion to HQ repre-
sents a minor pathway. This further suggests that phe-
nol may be predominantly metabolized to biphenols,
which, followingoxidationto their semi-quinone andqui-
none entities, can bind to DNA.
The putative reactive metabolites derivedfrom HQ are
likelytobep-benzosemiquinone and/orBQ, which canbe
formed eitherby autoxidation ofHQatphysiological pH
inthepresence ofoxygenorby enzyme-mediated oxida-
tionofHQ(4,25,26). In addition, HQcanbe convertedto
BT, which can autoxidize to electrophiles such as a-
hydroxy-p-benzosemiquinone and a-hydroxy-p-benzo-
quinone (4,25,26). Since only a minor fraction ofHQ ad-
ducts (Fig. 5, adducts 6 and 8, composing < 20%) cor-
responded to BQ- and BT-derived modifications (Fig. 5,
adducts 6, 8, andb), it appears that in Zymbalgland cul-
ture, BQ and BT are minor reactive intermediates
formedfrom HQ, while thep-benzosemiquinone maypre-
dominate.
The DNA-reactive species derived from catechol may
be either a mixture of o-benzosemiquinone and o-
benzoquinone formed by enzyme mediated-oxidation or
a mixture of semiquinone and quinone species of BT
(4,25,26). About 20% oftotal modifications produced by
catechol exhibited chromatographic properties similar to
those derivedfrom BT(Table 1), indicatingthatthe con-
version ofcatecholto BTis aminorpathway. Therefore,
the alternate pathway leading to the formation of the
semiquinone andquinone isprobablythemajorone. The
unique 32P-fingerprints for eachmetabolite tested(Figs.
5 and 6) are consistent with the data of Rushmore et al.
(27), who have observed different Sephadex LH-20
column proflles of dG adducts in 3H-GMP-prelabeled
DNA ofrabbitbone marrowmitoplasts exposedinvitro
to HQ, BQ, phenol, catechol, and BT.
Although phenol or other metabolites of benzene in-
duced relatively high levels of adducts, benzene itself
produced adducts atlevelsbarely detectable bythe 32P-
postlabeling assay. This couldresultfrom a)less efficient
conversion ofbenzene tophenol in the Zymbalgland cul-
tures; b) the high volatility ofbenzene, reducing the ef-
fective dose reaching Zymbal glands in the culture
medium; and/or c) the metabolism of benzene predom-
inantly to aring-opened derivative(28), whichmayform
polar adducts not detectable by postlabeling under the246 REDDY ETAL.
Table 1. Levels ofDNA adducts formed in Zymbal glands in culture treated with benzene and its metabolites, as estimated by a nuclease
Pi-enhanced postlabeling.a
Concentration, ~~RAL x 109 for adduct spotb (No. of adducts per 109 DNA nucleotides) Concentratio n,,
Compound jAg/mL a b c d e Others Total
Catechol 1500 16.2 3.0 6.0 NCC 5.2 15.0 45.4
(36)d (7) (13) (11) (33)
BT 1500 NDe 20.2 8.7 5.1 8.4 10.3 52.7
(38) (17) (10) (16) (20)
1 5 6 7 23 24 Others Total
Phenol 750 30.7 ND ND ND 33.5 ND 9.4 73.6
(42) (46) (13)
1500 75.1 ND 3.5 ND 52.9 ND 14.8 146
(52) (2) (36) (10)
HQ 750 36.1 317 39.6 260f 254 90.2 83.5 1080
(3) (29) (4) (24) (24) (8) (8)
1500 53.3 269 228 202 215 121 162 1250
(4) (22) (18) (16) (17) (10) (13)
BQ 1500 ND ND 1370 ND ND ND 614 1984
(69) (31)
Benzene "'1800 NC 0.5 0.5
aAdduct spots (Figs. 5 and 6) were cut from the chromatograms and counted by Cerenkov assay. RAL values were calculated from count rates
using the specific activity ofy-32P-ATP (7,8).
bFor adduct assignments, see Figs. 5 and 6.
CNot countable.
dNumbers in parentheses indicate percentages of each adduct relative to total.
'Not detected.
fThe recovery ofthis adduct varied markedly. The value represents a maximum estimate.
experimental conditions described. Currently, none of
these possibilities can be dismissed.
Reaction ofBQorHQwith dGhasbeen shownbyJowa
et al. (29) to generate (3'OH)benzetheno(N1,N2)dG as the
major derivative on the basis ofHPLC and NMR analy-
sis. Incomparisonwith this data, adduct6, whichwas de-
tected asthemajorproductofthe interaction ofBQwith
DNA or dGp (Fig. 5), may be (3'OH)-benzetheno-
(N1,N2)deoxyguanosine 3',5'-1[32P]bisphosphate. The de-
tection ofmultiple 32P-postlabeled adductswith HQ-DNA
is in accordance with the multiple HPLC peaks obtained
from the hydrolysate of calf thymus DNA modified in
vitro by 14C-HQ (29).
Analysis of AAF adducts here (Fig. 4) and those of
4-aminobiphenyl previously (7,8) indicate that the
C8-guanine derivatives are susceptible to 3'-dephos-
phorylation bynucleasePi, while the N2-guanine deriva-
tives are not. Adducts of benzo[a]pyrene, safrole, and
mitomycin C, which predominantly bind at the N2 posi-
tion ofguanine, have also been shown to be resistant to
the enzyme activity (7,8). Taken together, the data sug-
gest that an adducted 3'-nucleotide with a carcinogen
bound to a base at the exocyclic position, but not at the
endocyclic position, is resistant to nuclease P -mediated
dephosphorylation. When the attachment is simultane-
ously atthe exocyclic andendocyclicpositions, forexam-
ple, a cyclic adduct, as inthe case ofthe major adduct of
BQ-DNA above, the adductmaynotbe susceptible tothe
enzyme activity (21). Such differential enzyme activity
may be useful in adduct characterization.
Ourresults demonstrate theutilityofpostlabelingtech-
niques to determine the capacity of tissues or cells to
metabolize amutagen/carcinogen ofinterest bymeasur-
ing DNA adduct fonnation. Because ofhigh sensitivity
andthe needforonly afewmicrograms ofDNA, the 32p
postlabeling assay affords adduct measurement in a small
number ofcells, as evident from the present studies on
Zymbal glands weighing only about 15 mg per rat. The
32P-postlabeling protocol, withfurtherrefinement to re-
duce background noise, may potentially be applicable to
monitor the formation of DNA adducts in blood cells of
humans exposed to benzene and thereby provide useful
information for risk assessment and management.
By combining the highly sensitive postlabeling assay
withthe newly devised Zymbal culture system, we have
begun to elucidate the metabolic pathways and macro-
molecular interactions in this target tissue. Insights
gainedfrom thisworkwill subsequentlybeappliedtothe
design and interpretation of analogous in vivo studies,
with the ultimate goal of better understanding the
mechanisms involved in the carcinogenic process.
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